Beam Therapeutics
BEAM
#3868
Rank
A$3.95 B
Marketcap
$47.78
Share price
-8.30%
Change (1 day)
-1.53%
Change (1 year)

Beam Therapeutics (BEAM) Fails to deliver data

Key failure to deliver metrics for Beam Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Beam Therapeutics (BEAM) - 3 months history

Number of shares, 3 months chart

Dec 2024Jan 20255K10K15K20K25K30K0companiesmarketcap.com

Biweekly Failures to deliver volume for Beam Therapeutics (BEAM) - since 2020

Volume in USD (price x number of shares), data since 2020 20212022202320242025$20M$40M$60M$80M$0.1B$0.12B0companiesmarketcap.com

Beam Therapeutics (BEAM) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.13 M-99.38%
2024A$21.66 M-23.72%
2023A$28.39 M-67.01%
2022A$86.08 M-64.17%
2021A$0.24 B336.3%
2020A$55.06 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$4.24 MA$8.64 M๐Ÿ‡บ๐Ÿ‡ธ USA